首页 | 本学科首页   官方微博 | 高级检索  
检索        

胸腔置管联合透明质酸钠防治结核性胸膜炎胸膜肥厚:成本效果分析
引用本文:周爱莲,孙俊生,何建猷.胸腔置管联合透明质酸钠防治结核性胸膜炎胸膜肥厚:成本效果分析[J].中国防痨通讯,2009,31(8):487-490.
作者姓名:周爱莲  孙俊生  何建猷
作者单位:1.深圳市第五人民医院 深圳 518000;2.西安高新医院 西安 710075;3.广东医学院呼吸疾病研究所 湛江 524001
摘    要:目的探索防治结核性胸膜炎胸膜肥厚成本低、效果好的治疗方法。方法64例中至大量游离结核性胸腔积液患者随机分为治疗组和对照组。治疗组胸腔置管完全引流积液后注入透明质酸钠,对照组常规胸穿抽液。统计治疗3个月后2组花费的成本,进行成本效果分析及敏感度分析。 结果59例患者参与最后结果分析。治疗3个月后治疗组、对照组胸膜肥厚发生率是6.7%、31.0%(有效率分别是:93.3%、69.0%)(P<0.05);成本效果比(C/E)是35.19,47.53,敏感度分析显示C/E 35.63,49.00。结论胸腔置管联合透明质酸钠防治结核性胸膜炎胸膜肥厚是成本低、效果好的方法。

关 键 词:结核    胸膜/并发症  结核    胸膜/经济学  胸膜疾病  引流术  透明质酸  成本及成本分析  

Intrathoracic cannula combining with sodium hyaluronate to prevent pleural thickening of tuberculous pleurisy: cost/effective analysis
Zhou Ailian,Sun Junsheng,He Jianyou.Intrathoracic cannula combining with sodium hyaluronate to prevent pleural thickening of tuberculous pleurisy: cost/effective analysis[J].The Journal of The Chinese Antituberculosis Association,2009,31(8):487-490.
Authors:Zhou Ailian  Sun Junsheng  He Jianyou
Institution:1.Department of respiratory medicine, Shenzhen No.5 Hospital, Shenzhen 518000, China;2.Gaoxing Hospital of Xi’an, Xi’an 710075, China;3.The Institute of Respiratory Disease of Guangdong Medical college, Zhenjiang 524001, China
Abstract:Objective To explore the method of lower cost and better results, to prevent pleural thiekening(PT) of tuberculous pleurisy. Methods Sixty-four patients with middle to large pleru-ral effusions were randomly assigned to a treatment group and a control group. Patients in treat-ment group given with sodium hyaluronate via central venous catheter into the thoracic cavity after pleural effusion was drainaged completely,while patients in control group received routine thoraeen-tesis. We calculated the cost after 3 months in two groups respectively and analyzed the cost-effec-tiveness and sensitivity. Results Fifty-nine patients were available for final analysis. The inci-dence rate of PT at 3rd month were 6.7% in treatment group and 31.0% in control group(the effec-tive rate: 93.3% vs. 69.0%, respectively) with statistically significant difference(P<0.05) ; The cost/effective rate were 35.2 in the treatment group and 47. 5 in the control group. Sensitivity anal-ysis showed 35.6 in the treatment group and 49.00 in the control group. Conclusions Intrathorac-ic cannula combining with administration of sodium hyaluronate is a method of lower cost and better results to prevent pleural thickening of tuberculous pleurisy.
Keywords:Tuberculosis  pleural/complications  Tuberculosis  pleural/economics  Pleural disea-ses  Drainage  Hyaluronic acid  Costs and cost analysis
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国防痨通讯》浏览原始摘要信息
点击此处可从《中国防痨通讯》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号